A B S T RA C T Measurement of urine to blood (U-B) carbon dioxide tension (Pco2) gradient during alkalinization of the urine has been suggested to assess distal H+ secretion. A fact that has not been considered in previous studies dealing with urinary Pco2 is that dissolution of HCO3 in water results in elevation of Pco2 which is directly proportional to the HCO3 concentration. To investigate the interrelationship of urinary HCO3 and urinary acidification, we measured U-B Pco2 in (a) the presence of enhanced H+ secretion and decreased concentrating ability i.e., chronic renal failure (CRF), (b) animals with normal H+ secretion and decreased concentrating ability, Brattleboro (BB) rats, and (c) the presence of both impaired H+ secretion and concentrating ability (LiCl treatment and after release of unilateral ureteral obstruction). At moderately elevated plasma HCO3 levels (30-40 meq/liter), normal rats achieved a highly alkaline urine (urine pH > 7.8) and raised urine HCO3 concentration and U-B Pco2. At similar plasma HCO3 levels, BB rats had a much higher fractional water excretion and failed to raise urine pH, urine HCO3 concentration, and U-B Pco2 normally. At a very high plasma HCO3 (>50 meq/liter), BB rats raised urine pH, urine HCO3 concentration, and U-B Pco2 to the same levels seen in normals. CRF rats failed to raise urine pH, urine HCO3, and U-B Pco2 normally at moderately elevated plasma HCO3 levels; at very high plasma HCO3 levels, CRF rats achieved a highly alkaline urine but failed to raise U-B Pco2. Dogs and patients with CRF were also unable to raise urine pH, urine HCO3 concentration, and U-B Pco2 normally at moderately elevated plasma HCO3 levels. In rats, dogs, and man, U-B Pco2 was directly related to urine HCO3 concentration and inversely related to fractional water excretion. At moderately elevated plasma HCO3 levels, animals with a distal acidification defect failed to raise U-B Pco2; increasing the plasma HCO3 to very high levels resulted in a significant increase in urine HCO3 concentration and U-B Pco2. The observed urinary Pco2 was very close to the Pco2 which would be expected by simple dissolution of a comparable amount of HCO3 in water. These data demonstrate that, in highly alkaline urine, urinary Pco2 is largely determined by concentration of urinary HCO3 and cannot be used as solely indicating distal H+ secretion.
INTRODUCTION
It has been well established that alkalinization of the urine is associated with elevation of urinary carbon dioxide tension (Pco2)1 in excess of blood Pco2 (1) . More recently, it has been suggested that measurement of the urine to blood (U-B) Pco2 gradient in alkaline urine can be used to assess distal hydrogen ion secretion (2) (3) (4) . We have recently demonstrated that in highly alkaline urine (urine pH > 7.8), U-B Pco2 is not influenced by acute decreases in glomerular filtration rate (GFR), urine flow, bicarbonate excretion, phosphate concentration and excretion, and parathyroid hormone administration (4, 5) . The failure of U-B Pco2 to rise with alkalinization of the urine has been taken as evidence of a distal acidification defect (2, 4) . Steinmetz et al. (6) indicated, however, that, to interpret the meaning of low urinary Pco2 in distal renal tubular acidosis, one must take into account urinary bicarbonate concentration. Inasmuch as urinary Pco2 is related to urinary bicarbonate concentration, it is possible that the concentrating defect of patients with distal renal tubular acidosis may account at least in part for the low urinary Pco2 (6) . One observation that remains unexplained is the failure of patients with chronic renal failure (CRF) to raise U-B Pco2 with alkalinization of urine (7) (8) (9) . This phenomenon is somewhat surprising in that studies of acid excretion in CRF have demonstrated that net acid excretion per nephron is enhanced in renal failure (10, 11) . In the present study we evaluated the factors controlling the formation of urinary Pco2 in CRF in animals with concentrating defects and(or) acidification defects.
METHODS

Studies in rats
The rats were allowed a normal food and water intake before the day of study. They were anesthetized with 10 mg/100 g Inactin (Promonta, Hamburg, West Germany) given intraperitoneally. Tracheostomy was performed, and one carotid artery and jugular vein were cannulated. The bladder was catheterized through an abdominal incision. Blood pressure was monitored throughout the experiment. At the start of the experiment, 1251-iothalamate diluted in saline 0.75 ,uCi/ml was infused by an infusion pump at a rate of 0.024 ml/min throughout the course of the experiment as a marker of GFR. A 60-min equilibration period was allowed before any collection was started. Urine samples were collected under mineral oil in preweighed glass vials, and the urine volume was determined gravimetrically. Blood samples were collected from the carotid artery during the midportion of each clearance collection; collections were of a 20-min duration. The following groups of rats were studied:
Group I -normal rats. 10 normal rats, weighing between 200 and 300 g, were infused with 0.9 M NaHCO3 at a rate of =6 ml/h to achieve a stable plasma HCO3 level between 30 and 40 meq/liter. Once the plasma concentration had reached the desired level, three to four collections were obtained.
Group II -CRF rats. 10 normal rats, weighing between 200 and 300 g, had the secondary branches of the renal artery dissected and ligated to produce infarction of approximately 80% of the kidney. 1 wk later the contralateral kidney was removed. These rats were studied _10 days later. 0.9 M NaHCO3 was infused at a rate of 6 ml/h to increase plasma HCO3 between 30 and 40 meq/liter; three clearance collections were then obtained. The infusion was then increased to 8 ml/h; when the urine pH reached a value >7.8, two to three additional collections were obtained.
Group III Brattleboro rats. Six Brattleboro (BB) rats, weighing between 125 and 175 g, were infused with 0.9 M NaHCO3 at a rate of -6 ml/h; when plasma HCO3 reached a stable level between 30 and 40 meq/liter, two collections were obtained. NaHCO3 infusion was then increased to 8 ml/h; when the urine pH was >7.8, two to three additional collections were obtained.
Studies in dogs
The dogs were anesthetized with sodium pentobarbital (30 mg/kg, iv.); subsequent small doses were administered as needed to maintain light anesthesia. An arterial catheter was used to sample blood. 1251-iothalamate in 0.9% saline (115 ,uCi/liter) was infused at a rate of 0.6 ml/min as a marker of GFR. An endotracheal tube was inserted and connected to a Bird respirator (Bird Corp., Palm Springs, Calif.); arterial Pco2 was maintained between 40 and 50 mm Hg by appropriate manipulation of the respirator. An equilibration period of at least 40 min was allowed before starting collections. The following groups of dogs were studied:
Group I -chronic renal failure dogs. Six normal dogs were infused with 0.9 M NaHCO3 to achieve a stable plasma HCO3 level between 30 and 40 meq/liter. When this level was achieved, three to four collections were obtained. 1 wk later these dogs were operated on under sterile conditions. The secondary and tertiary branches were dissected and ligated to produce infarction of 80% of the kidney as described by Schultze et al. (12) . The contralateral kidney was removed 1 wk later. 7-10 days later these animals underwent the second part of the study using a protocol identical to that used in the first part of the study.
Three additional dogs were also studied. The first part of the study was identical to that described above. In the second part of the study the diseased kidney was studied in the presence of the contralateral kidney.
Group II -lithium-treated dogs. Five normal dogs were treated with LiCl, 3 meq/kg intraperitoneally for 3 days including the day of the study. Urine was collected from bilateral ureteral catheters. NaHCO3 (0.9 M was infused at a bolus dose of 100 meq followed by 1 ml/min in order to achieve a urine pH > 7.8. After a 30-min equilibration period, two to three collections were obtained. NaHCO3 infusion was then increased to 2-3 ml/min in order to achieve a plasma HCO3 value >50 meq/liter. The ureteral pressure of one kidney was eleyated to 40-60 mm of H20 to prevent an increase in urine flow. Two to three additional urine and blood samples were then obtained. A previous study from this laboratory has shown that elevation of ureteral pressure does not influence urinary Pco2 (4).
Group III-unilateral ureteral obstruction. Four normal dogs had one ureter ligated completely under anesthesia. 18-24 h later both ureters were identified and cannulated. After urine flow had become stable, urine collections were started. NaHCO3 (0.9 M) was infused at a rate of 1 ml/min to achieve a urine pH > 7.8. Two to three clearance collections were obtained. The infusion of NaHCO3 was increased to 2-3 ml/min until the plasma HCO3 levels were >50 meq/liter. Additional urine and blood samples were then obtained.
Studies in humans
Eight patients with CRF were included in this study.
This research protocol was approved by the Institutional Review Committee at the University of Illinois and West Side Veterans Administration Hospitals. All patients gave informed consent to participate in the study. The cause of CRF was chronic glomerulonephritis (three patients), nephrosclerosis (four patients), and systemic lupus erythematosus (one patient). Patients with the nephrotic syndrome, obstructive uropathy, chronic pyelonephritis, congestive heart failure, and diabetes were excluded from the study. All patients included were in stable condition at the time of the study. They were ingesting a normal diet containing =60-100 meq of NaCl/day and were studied at the time of their hospital admission for evaluation for chronic hemodialysis. The patients who were on diuretics had these drugs discontinued for at least 3 days before the study.
The normal subjects included in this study were six healthy subjects (four of the six are authors of this paper) who volunteered for the study. All patients and normal subjects were encouraged to ingest substantial amounts of water 2 h before the study to achieve a good urine flow. 1 h before the study, 10 ,uCi 1251-iothalamate with 0.1 ml epinephrine was injected subcutaneously. One intravenous catheter was used for infusion of NaHCO3; in the opposite arm another intravenous catheter was used to sample blood. Blood for determination of base-line plasma electrolytes and blood gases were collected before starting infusion of NaHCO3. NaHCO3 (0.9 M) was given at a bolus dose of 100-150 meq followed by infusion at a rate of2-3 ml/min. When plasma HCO3 achieved a stable level above 30 meq/liter, the bladder was emptied completely, and clearance collections were started. Collections were of a 10-30-min duration. Blood and urine were sampled at the midpoint of each collection. No Foley catheter was used in the study, because neither patients nor the normal subjects had any difficulty in emptying the bladder. Three to four collections were obtained in each subject.
Studies in vitro
Four different urine samples from bicarbonate-loaded dogs who had a highly alkaline urine were studied in vitro. 
RESULTS
Studies in rats
The mean GFR in normal and CRF rats was 3.17 +0. 18 and 0.33+0.06 ml/min, respectively (P < 0.001). BB rats had a mean GFR of 1 FIGURE 2 U-B Pco2 is plotted against fractional water excretion, (V/GFR) x 100, for normal, BB, and CRF rats.
normal rats had a highly alkaline urine and significantly elevated urine Pco2 and U-B Pco2 ( It is clear that U-B Pco2 is inversely related to V/GFR (y = 37.8 -0.82x, r = 0.82, P < 0.005), and directly to urine HCO3 concentration (y = -8.5 + 0.24x, r = 0.88, P < 0.005) (Fig. 3) .
Studies in dogs
Normal and CRF dogs. In CRF urine pH, urine HCO3 concentration and U-B Pco2 were significantly lower than in control despite identical plasma HCO3 levels and similar V (Table II, Fig. 4) . Observe, however, that (V/GFR) x 100 was significantly higher in CRF than in normal dogs. U-B Pco2 was inversely related to (V/GFR) x 100 ( Fig. 5 ) (y = 20.8 -0.55x, r = 0.72, P < 0.025).
In the presence of a normal contralateral kidney, the diseased kidney also failed to raise U-B Pco2 (Fig. 6) . Observe, however, that the diseased kidney achieved a urine pH of the same magnitude as that of the normal kidney. Urine HCO3 concentration was also decreased in the diseased kidney.
Li-treated dogs. Li-treated dogs developed hyperchloremic metabolic acidosis with an alkaline urine (Table III) . At a plasma HCO3 of 37.5 meq/liter, Litreated dogs had a highly alkaline urine, but U-B Pco2 was only 14 .0+2.80 mm Hg, which is significantly lower than that of normal dogs (Tables II and  IV) . Increasing the plasma HCO3 levels to 62.8 meq/ liter, with simultaneous elevation of the ureteral pressure in one kidney, resulted in a significant increase in urine osmolality, urine HCO3 concentration, and in U-B Pco2. In the contralateral kidney, urine HCO3 concentration, urine osmolality, and U-B Pco2 failed to rise (Table IV) .
Unilateral ureteral obstruction. After the release of unilateral obstruction, the post-obstructed kidney POK) had a significantly higher baseline urine pH than the contralateral kidney (CK) ( Table V) . GFR 
Studies in humans
The mean GFR in normal subjects was 140.7+9.58 ml/min and that of CRF patients was 18.7+9.54 ml/min (P < 0.001). U-B Pco2 in the normal subjects and in patients with CRF are shown in Table VI and Fig. 8 . Observe that subjects L. N., J. A., and P. C. failed to achieve a highly alkaline urine and to raise U-B Pco2 despite high plasma bicarbonate levels; these subjects were excreting a high fraction of the filtered water and, therefore, had a low urinary HCO3 concentration. Subjects J. S., G. A., and M. R. excreted a much lower fraction of filtered water and were able to raise urine HCO2 concentration. All patients with CRF excreted a high fraction of the filtered water and thus failed to raise urine HCO3 concentration and U-B Pco2. U-B Pco2 was inversely related to (V/GFR) x 100 (y = 26.7 -0.54x, r = 0.56, P < 0.05) (Fig. 8) .
Studies in vitro
Table VII shows that the addition of NaHCO3 to highly alkaline dog urine in vitro uniformly results in a marked elevation of Pco2 while the pH remains constant.
DISCUSSION
The demonstration that the urinary Pco2 is considerably greater than that of blood during bicarbonate loading has been felt to signify the presence of an intact distal acidification mechanism (2) (3) (4) (Table I ). Fig. 10 shows tion is examined in normal, BB, and CRF rats. Fig. 9 similar calculations for BB rats. At a plasma HCO3 of shows that, at a plasma HCO3 of 35 meq/liter, normal 35 meq/liter, BB rats had a fractional water excretion of rats have a HCO3 concentration of 17 meq/liter in 10% and based on Tm/GFR of 33 meq/liter, BB rats the end of the proximal tubule; these calculations were able to raise urine HCO3 only to 20 meq/liter, are made on the basis of the observed GFR, plasma a value close to that observed in vivo (Table I) . The HCO3, and Tm/GFR in vivo and on the assumption theoretical calculations presented in Fig. 10 show that that there is 60% fluid reabsorption in the proximal all that is required to raise urinary HCO3 concentration to the levels observed is a plasma concentration of 55 meq/liter. In BB rats, at a highly alkaline urinary pH, the observed urinary Pco2 is also very close to that predicted from the concentration of HCO3. In CRF, however, an increase in plasma HCO3 to very high levels failed to increase urinary HCO3, because the fraction of the excreted filtered water also increased twofold. It is obvious from the calculations in Fig. 11 that, in CRF, a plasma HCO3 in excess of 200 meqlliter would be necessary to attain a urine HCO3 similar to that seen in normals. In CRF and in BB rats, at a lower urinary pH, the observed urinary Pco2 is higher than the calculated Pco2. Two These observations suggest that the ability to remove water in the collecting duct and therefore raise urinary HCO3 concentration is essential for the formation of a high urinary Pco2 in a highly alkaline urine. It must be emphasized that our study, as do all previous such studies, measures urinary pCO2 in urine that has left the kidney. The Pco2 measured in these urine samples may or may not reflect the Pco2 in the collecting duct. Two possibilities concerning the Pco2 in the collecting duct immediately present themselves. First, as water is abstracted from the collecting duct, bicarbonate concentration rises, and Pco2 likewise increases. Assuming that the collecting duct is highly permeable to CO2 (an assumption that has been made by almost all workers in the field), then The high urinary Pco2 of alkaline urine has been attributed to several mechanisms which include delayed dehydration of carbonic acid (6), mixing of acid and alkaline urine, trapping of medullary CO2, and restriction to diffusion of CO2 across the collecting duct (1, 4, 25, 26 (4) . Hydrogen ion secretion in the collecting duct will result in a disequilibrium pH and titration of phosphate according to the following reaction: H+ + HPO;= H2PO4 As the tubular fluid proceeds towards equilibrium, the pH will rise, and H2PO4 will react with HCO3, thus increasing the Pco2. Previous studies have suggested that it is possible to increase urinary Pco2 in man undergoing water diuresis (27, 28) . In these experiments urine bicarbonate and phosphate concentrations were very low, and it is difficult to explain the mechanism responsible for the elevation of urinary Pco2.
The observation that carbonic anhydrase administration lowers urinary Pco2 to the level of blood Pco2 whereas urinary bicarbonate concentration remains unchanged (29) could be used as an argument against the thesis that urinary bicarbonate concentration is the main determinant of urinary Pco2 in highly alkaline urine. The dissipation of the U-B Pco2 gradient after carbonic anhydrase administration has been interpreted as indicating the existence of carbonic acid offofequilibrium (acid disequilibrium pH) in the distal nephron (29, 30) . The addition of carbonic anhydrase either to a solution of bicarbonate or to urine with a high Pco2 (in vitro) lowers the Pco2 of these solutions to very low levels (31) . When the solutions are kept under oil, carbonic anhydrase fails to lower the Pco2. Obviously there cannot be a disequilibrium pH in a solution of bicarbonate, and the mechanism whereby carbonic anhydrase lowers the Pco2 of this solution must lie elsewhere. It is possible that carbonic anhydrase, by accelerating the dehydration of carbonic acid, raises the Pco2 at the interface of the liquid and the air and therefore favors diffusion of CO2 into air; there is then a shift of the equilibrium of the following reaction: H+ + HCO3 H2CO3 =CO2 to the right with a consequent elevation of the pH of the solution because of the continuing loss of CO2. This explanation is supported by the fact that carbonic anhydrase fails to lower Pco2 appreciably when the sample was kept under oil. Thus, the previous experiments with infusion carbonic anhydrase can be used neither to support the existence of a disequilibrium pH in the collecting duct nor to indicate that the mechanism of elevation of the urinary Pco2 is due to delayed dehydration of carbonic acid. The observations do not exclude the existence of a disequilibrium pH in the distal nephron; the demonstration of such a phenomenon must use evidence other than that derived -from carbonic anhydrase administration.
In conclusion, in highly alkaline urine, urinary Pco2 is critically dependent on urinary bicarbonate concentration. The failure of urinary bicarbonate concentration to rise impairs the increase in urinary Pco2, even though hydrogen ion secretion is either normal or enhanced, e.g., diabetes insipidus and CRF. The urinary Pco2 found in highly alkaline urine is very close to that expected from the behavior of a similar solution ofbicarbonate in vitro. These data suggest that, in highly alkaline urine, urinary Pco2 largely reflects urinary concentration.
